BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 19522026)

  • 21. Improved gene transfer efficiency to primary and established human pancreatic carcinoma target cells via epidermal growth factor receptor and integrin-targeted adenoviral vectors.
    Wesseling JG; Bosma PJ; Krasnykh V; Kashentseva EA; Blackwell JL; Reynolds PN; Li H; Parameshwar M; Vickers SM; Jaffee EM; Huibregtse K; Curiel DT; Dmitriev I
    Gene Ther; 2001 Jul; 8(13):969-76. PubMed ID: 11438831
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Avidin-based targeting and purification of a protein IX-modified, metabolically biotinylated adenoviral vector.
    Campos SK; Parrott MB; Barry MA
    Mol Ther; 2004 Jun; 9(6):942-54. PubMed ID: 15194061
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enhanced pancreatic cancer gene therapy by combination of adenoviral vector expressing c-erb-B2 (Her-2/neu)-targeted immunotoxin with a replication-competent adenovirus or etoposide.
    Liu X; Li J; Tian Y; Xu P; Chen X; Xie K; Qiu Z; Wang Y; Zhang D; Wolf F; Li C; Huang Q
    Hum Gene Ther; 2010 Feb; 21(2):157-70. PubMed ID: 19751100
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Simultaneous CAR- and alpha V integrin-binding ablation fails to reduce Ad5 liver tropism.
    Martin K; Brie A; Saulnier P; Perricaudet M; Yeh P; Vigne E
    Mol Ther; 2003 Sep; 8(3):485-94. PubMed ID: 12946322
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A genetically retargeted adenoviral vector enhances viral transduction in esophageal carcinoma cell lines and primary cultured esophageal resection specimens.
    Buskens CJ; Marsman WA; Wesseling JG; Offerhaus GJ; Yamamoto M; Curiel DT; Bosma PJ; van Lanschot JJ
    Ann Surg; 2003 Dec; 238(6):815-24; discussion 825-6. PubMed ID: 14631218
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CAR-binding ablation does not change biodistribution and toxicity of adenoviral vectors.
    Alemany R; Curiel DT
    Gene Ther; 2001 Sep; 8(17):1347-53. PubMed ID: 11571572
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fibroblast growth factor-2-retargeted adenoviral vector for selective transduction of primary glioblastoma multiforme endothelial cells.
    Gupta V; Wang W; Sosnowski BA; Hofman FM; Chen TC
    Neurosurg Focus; 2006 Apr; 20(4):E26. PubMed ID: 16709032
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adenovirus vectors with chimeric type 5 and 35 fiber proteins exhibit enhanced transfection of human pancreatic cancer cells.
    Toyoda E; Doi R; Kami K; Mori T; Ito D; Koizumi M; Kida A; Nagai K; Ito T; Masui T; Wada M; Tagawa M; Uemoto S
    Int J Oncol; 2008 Dec; 33(6):1141-7. PubMed ID: 19020746
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enhanced gene transfer to rabbit jugular veins by an adenovirus containing a cyclic RGD motif in the HI loop of the fiber knob.
    Hay CM; De Leon H; Jafari JD; Jakubczak JL; Mech CA; Hallenbeck PL; Powell SK; Liau G; Stevenson SC
    J Vasc Res; 2001; 38(4):315-23. PubMed ID: 11455202
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Midkine promoter-based conditionally replicative adenovirus therapy for midkine-expressing human pancreatic cancer.
    Toyoda E; Doi R; Kami K; Mori T; Ito D; Koizumi M; Kida A; Nagai K; Ito T; Masui T; Wada M; Tagawa M; Uemoto S
    J Exp Clin Cancer Res; 2008 Aug; 27(1):30. PubMed ID: 18717994
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Uptake of adenoviral vectors via fibroblast growth factor receptors involves intracellular pathways that differ from the targeting ligand.
    Hoganson DK; Sosnowski BA; Pierce GF; Doukas J
    Mol Ther; 2001 Jan; 3(1):105-12. PubMed ID: 11162317
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Potent antitumor effect of neurotensin receptor-targeted oncolytic adenovirus co-expressing decorin and Wnt antagonist in an orthotopic pancreatic tumor model.
    Na Y; Choi JW; Kasala D; Hong J; Oh E; Li Y; Jung SJ; Kim SW; Yun CO
    J Control Release; 2015 Dec; 220(Pt B):766-82. PubMed ID: 26471393
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Targeting EGFR with metabolically biotinylated fiber-mosaic adenovirus.
    Pereboeva L; Komarova S; Roth J; Ponnazhagan S; Curiel DT
    Gene Ther; 2007 Apr; 14(8):627-37. PubMed ID: 17251987
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PCI-enhanced adenoviral transduction employs the known uptake mechanism of adenoviral particles.
    Engesaeter BØ; Bonsted A; Berg K; Høgset A; Engebråten O; Fodstad Ø; Curiel DT; Maelandsmo GM
    Cancer Gene Ther; 2005 May; 12(5):439-48. PubMed ID: 15678152
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fiber-knob modifications enhance adenoviral tropism and gene transfer in malignant glioma.
    Zheng S; Ulasov IV; Han Y; Tyler MA; Zhu ZB; Lesniak MS
    J Gene Med; 2007 Mar; 9(3):151-60. PubMed ID: 17351980
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reduction of natural adenovirus tropism to the liver by both ablation of fiber-coxsackievirus and adenovirus receptor interaction and use of replaceable short fiber.
    Nakamura T; Sato K; Hamada H
    J Virol; 2003 Feb; 77(4):2512-21. PubMed ID: 12551989
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of the putative heparan sulfate glycosaminoglycan-binding site of the adenovirus type 5 fiber shaft on liver detargeting and knob-mediated retargeting.
    Bayo-Puxan N; Cascallo M; Gros A; Huch M; Fillat C; Alemany R
    J Gen Virol; 2006 Sep; 87(Pt 9):2487-2495. PubMed ID: 16894186
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Receptor interactions involved in adenoviral-mediated gene delivery after systemic administration in non-human primates.
    Smith TA; Idamakanti N; Marshall-Neff J; Rollence ML; Wright P; Kaloss M; King L; Mech C; Dinges L; Iverson WO; Sherer AD; Markovits JE; Lyons RM; Kaleko M; Stevenson SC
    Hum Gene Ther; 2003 Nov; 14(17):1595-604. PubMed ID: 14633402
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gene therapy for esophageal carcinoma: the use of an explant model to test adenoviral vectors ex vivo.
    Marsman WA; Buskens CJ; Wesseling JG; Offerhaus GJ; Bergman JJ; Tytgat GN; van Lanschot JJ; Bosma PJ
    Cancer Gene Ther; 2004 Apr; 11(4):289-96. PubMed ID: 14765131
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel recombinant adenoviral vector that targets the interleukin-13 receptor alpha2 chain permits effective gene transfer to malignant glioma.
    Ulasov IV; Tyler MA; Han Y; Glasgow JN; Lesniak MS
    Hum Gene Ther; 2007 Feb; 18(2):118-29. PubMed ID: 17328684
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.